Affect and cannabis use in daily life: a review and recommendations for future research

Drug and Alcohol Dependence
Andrea M WycoffTimothy J Trull

Abstract

Although cannabis is often used for the purposes of relieving negative affective states such as anxiety and depression, the associations between cannabis use and affect in daily life are unclear. Ecological momentary assessment (EMA) has been used to study these associations in individuals' natural environments, providing more ecological validity, minimizing retrospective bias, and allowing for the analysis of within-individual processes over time. This review focuses on studies that utilized EMA to examine daily-life associations of cannabis use and negative and positive affective states. We review the findings of the 19 articles that met inclusion criteria, including clinical and community samples. Results provide equivocal evidence regarding relations between cannabis use and affect for community samples. Findings are mixed for clinical samples as well, but more consistent patterns emerge for general negative affect (NA) and anger/hostility at the momentary level; cannabis use may be more likely following increased NA and lead to decreases in NA and anger/hostility in psychiatric populations. Findings support a negative reinforcement hypothesis for clinical samples in terms of general NA and anger/hostility. However, discrep...Continue Reading

References

May 1, 1989·The International Journal of the Addictions·B W LexJ H Mendelson
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge
Mar 25, 1999·Psychopharmacology·M HaneyM W Fischman
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C L HartM W Fischman
Jul 11, 2002·Social Psychiatry and Psychiatric Epidemiology·Chuan-Yu ChenJames C Anthony
Aug 20, 2002·Annual Review of Psychology·Terry E Robinson, Kent C Berridge
Dec 21, 2002·The American Journal of Drug and Alcohol Abuse·Vito AgostiFrances Levin
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
May 22, 2003·Psychiatry Research·Marie TournierHélène Verdoux
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer McDonaldHarriet de Wit
Aug 29, 2003·Journal of Abnormal Psychology·Alan J BudneyJohn R Hughes
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Feb 6, 2004·Psychological Review·Timothy B BakerMichael C Fiore
Jul 21, 2006·Psychological Medicine·Frederick S StinsonBridget F Grant
Feb 19, 2008·Addiction Biology·Ziva D Cooper, Margaret Haney
Mar 7, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·K Luan PhanHarriet de Wit
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Mar 24, 2010·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Nadia ChakrounJoel Swendsen
May 22, 2010·Journal of Forensic Sciences·Zlatko MehmedicMahmoud A ElSohly
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Cécile HenquetInez Myin-Germeys
Nov 17, 2010·The American Journal of Psychiatry·Joel SwendsenEric Granholm
Mar 31, 2011·Depression and Anxiety·Julia D BucknerNorman B Schmidt
Aug 24, 2011·Journal of Psychoactive Drugs·Craig ReinarmanTom Heddleston
Sep 29, 2011·Journal of Behavior Therapy and Experimental Psychiatry·Julia D BucknerNorman B Schmidt
Jan 17, 2012·Journal of Anxiety Disorders·Julia D BucknerNorman B Schmidt
Feb 4, 2012·Addiction·Arpana AgrawalMichael T Lynskey
Jul 19, 2012·Annual Review of Psychology·Raphael Mechoulam, Linda A Parker
Nov 20, 2012·Annual Review of Clinical Psychology·Timothy J Trull, Ulrich Ebner-Priemer
Dec 12, 2012·Clinical Chemistry·Rebecca L Hartman, Marilyn A Huestis
May 15, 2013·Drug and Alcohol Dependence·Julia D BucknerAnthony H Ecker
Oct 19, 2013·Frontiers in Psychiatry·Raymond J M Niesink, Margriet W van Laar
Nov 12, 2013·The American Journal of Drug and Alcohol Abuse·Marcel O Bonn-MillerKimberly A Babson
Feb 1, 2011·Journal of Cognitive Psychotherapy·Jane MetrikDamaris J Rohsenow
Jun 18, 2014·Addictive Behaviors·John R HughesPeter W Callas
Sep 11, 2014·Journal of Studies on Alcohol and Drugs·Lydia A ShrierEmily A Blood
Sep 23, 2014·Journal of the International Neuropsychological Society : JINS·Jennifer L WinwardSandra A Brown
Jan 18, 2015·Drug and Alcohol Dependence·Emily B AnsellRajita Sinha
Aug 20, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret Haney, A Eden Evins
Sep 29, 2015·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Salpi KevorkianErin C Berenz
Nov 26, 2015·Journal of Psychoactive Drugs·Lawrence A OsbornBrent Lang

❮ Previous
Next ❯

Citations

Oct 28, 2019·Journal of Dual Diagnosis·Lucia SideliRobin M Murray
Aug 4, 2020·Annals of Internal Medicine·Christina A Brezing, Frances R Levin
Jun 17, 2020·Translational Psychiatry·Philip A SpechlerMartin P Paulus
Sep 22, 2020·Journal of Addiction Medicine·Christina A BrezingFrances R Levin
Oct 2, 2020·Drug and Alcohol Dependence·Philip A SpechlerUNKNOWN Tulsa 1000 Investigators
Sep 22, 2020·Journal of Affective Disorders·Andrea EscelsiorMario Amore
Mar 16, 2021·Frontiers in Psychiatry·Reilly R KayserHelen Blair Simpson
May 22, 2021·Journal of Substance Abuse Treatment·V Martínez-LoredoS Al-Halabí
Jun 1, 2021·Frontiers in Psychiatry·Catherine LangloisSmadar Valérie Tourjman
Feb 1, 2022·Substance Use & Misuse·Sara SemborskiBenjamin F Henwood

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.